Man Group PLC Annexon, Inc. Transaction History

Man Group PLC

  • $37.6 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$3.74 - $7.46 $466,164 - $929,836
124,643 Added 583.07%
146,020 $562,000
Q4 2022

Feb 14, 2023
BUY
$4.56 - $6.61 $97,479 - $141,301
21,377 New
21,377 $110,000
Q2 2022

Aug 15, 2022
BUY
$2.11 - $4.06 $31,785 - $61,159
15,064 New
15,064 $57,000

Others Institutions Holding ANNX

# of Institutions
156
Shares Held
101M
Call Options Held
3.73M
Put Options Held
1.3M
View Full List

About Annexon, Inc.

ANNX Quotes by TradingView
  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $335M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email